These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19339146)

  • 1. Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients.
    Fatséas M; Lavie E; Denis C; Auriacombe M
    J Subst Abuse Treat; 2009 Dec; 37(4):407-11. PubMed ID: 19339146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.
    Lavie E; Fatséas M; Denis C; Auriacombe M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):338-44. PubMed ID: 18824311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Can one talk of benzodiazepine "drunkenness"? About acute benzodiazepine intoxication, without suicidal or mortiferous tendencies].
    Menecier P; Texier MA; Las R; Ploton L
    Encephale; 2012 Feb; 38(1):25-30. PubMed ID: 22381720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment or "high": benzodiazepine use in patients on injectable heroin or oral opioids.
    Vogel M; Knöpfli B; Schmid O; Prica M; Strasser J; Prieto L; Wiesbeck GA; Dürsteler-Macfarland KM
    Addict Behav; 2013 Oct; 38(10):2477-84. PubMed ID: 23770646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome.
    de Wet C; Reed L; Glasper A; Moran P; Bearn J; Gossop M
    Drug Alcohol Depend; 2004 Oct; 76(1):31-5. PubMed ID: 15380286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of benzodiazepine craving with other clinical variables in a population of general practice patients.
    Mol AJ; Gorgels WJ; Oude Voshaar RC; Breteler MH; van Balkom AJ; van de Lisdonk EH; Kan CC; Zitman FG
    Compr Psychiatry; 2005; 46(5):353-60. PubMed ID: 16122535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
    Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
    Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-injurious behaviour, traumatic life events and alexithymia among treatment-seeking opiate addicts: prevalence, pattern and correlates.
    Oyefeso A; Brown S; Chiang Y; Clancy C
    Drug Alcohol Depend; 2008 Dec; 98(3):227-34. PubMed ID: 18639391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use in severe mental illness: self-medication and vulnerability factors.
    Bizzarri JV; Rucci P; Sbrana A; Miniati M; Raimondi F; Ravani L; Massei GJ; Milani F; Milianti M; Massei G; Gonnelli C; Cassano GB
    Psychiatry Res; 2009 Jan; 165(1-2):88-95. PubMed ID: 19054572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative evaluation of sharing practices of materials at risk for infectious virus contamination by intravenous opiate users seeking treatment--application of the RAB(Risk for AIDS Behavior) self-administered questionnaire].
    Bertorelle V; Auriacombe M; Grabot D; Franques P; Martin C; Daulouede JP; Tignol J
    Encephale; 2000; 26(3):3-7. PubMed ID: 10951900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benzodiazepine use in the elderly: the EVA Study].
    Lechevallier N; Fourrier A; Berr C
    Rev Epidemiol Sante Publique; 2003 Jun; 51(3):317-26. PubMed ID: 13130212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consumption patterns and motivation for use of addictive drugs in schizophrenic patients].
    Lambert M; Haasen C; Mass R; Krausz M
    Psychiatr Prax; 1997 Jul; 24(4):185-9. PubMed ID: 9340658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suicidal behavior, drug use and depressive symptoms after detoxification: a 2-year prospective study.
    Wines JD; Saitz R; Horton NJ; Lloyd-Travaglini C; Samet JH
    Drug Alcohol Depend; 2004 Dec; 76 Suppl():S21-9. PubMed ID: 15555813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-related risk behaviors among cocaine users.
    Khalsa HK; Kowalewski MR; Anglin MD; Wang J
    AIDS Educ Prev; 1992; 4(1):71-83. PubMed ID: 1311941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-treatment patterns among adolescent girls with dysmenorrhea.
    O'Connell K; Davis AR; Westhoff C
    J Pediatr Adolesc Gynecol; 2006 Aug; 19(4):285-9. PubMed ID: 16873033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Self medication by the adolescent].
    Jaquier F; Buclin T; Diezi J
    Schweiz Med Wochenschr; 1998 Feb; 128(6):203-7. PubMed ID: 9540142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.